Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Shering

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer|January 5, 1999
Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinomaS G Shering, F Sherry, E W McDermott, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Thyroid disorders and breast cancerS G Shering, A P Zbar, M Moriarty, et al.
The International Journal of Biological Markers|March 18, 1999
High levels of cathepsin B predict poor outcome in patients with breast cancerT M Maguire, S G Shering, C M Duggan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Assay of E-cadherin by ELISA in human breast cancersT M Maguire, S G Shering, E W McDermott, et al.
Irish Medical Journal|August 1, 1997
Cervical exploration for primary hyperparathyroidism--A 25 year experienceM A Rafferty, A D Hill, A P Zbar, et al.
Human Pathology|July 4, 1998
MDR1 expression is associated with adverse survival in melanoma of the uveal tractB M Dunne, M McNamara, M Clynes, et al.
Irish Medical Journal|June 5, 1998
A 25 year review of parotid surgeryA P Zbar, A D Hill, S G Shering, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinomaP P Smyth, S G Shering, M T Kilbane, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer|January 5, 1999
Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinomaS G Shering, F Sherry, E W McDermott, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Thyroid disorders and breast cancerS G Shering, A P Zbar, M Moriarty, et al.
The International Journal of Biological Markers|March 18, 1999
High levels of cathepsin B predict poor outcome in patients with breast cancerT M Maguire, S G Shering, C M Duggan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Assay of E-cadherin by ELISA in human breast cancersT M Maguire, S G Shering, E W McDermott, et al.
Irish Medical Journal|August 1, 1997
Cervical exploration for primary hyperparathyroidism--A 25 year experienceM A Rafferty, A D Hill, A P Zbar, et al.
Human Pathology|July 4, 1998
MDR1 expression is associated with adverse survival in melanoma of the uveal tractB M Dunne, M McNamara, M Clynes, et al.
Irish Medical Journal|June 5, 1998
A 25 year review of parotid surgeryA P Zbar, A D Hill, S G Shering, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinomaP P Smyth, S G Shering, M T Kilbane, et al.
Pageof 1